Unichem Laboratories Limited (BOM:506690)
542.75
+3.95 (0.73%)
At close: Aug 17, 2026
Unichem Laboratories Revenue
Unichem Laboratories had revenue of 6.48B INR in the quarter ending June 30, 2026, with 23.10% growth. This brings the company's revenue in the last twelve months to 23.17B, up 7.54% year-over-year. In the fiscal year ending March 31, 2026, Unichem Laboratories had annual revenue of 22.02B with 4.31% growth.
Revenue (ttm)
23.17B
Revenue Growth
+7.54%
P/S Ratio
1.64
Revenue / Employee
8.33M
Employees
2,780
Market Cap
37.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 22.02B | 908.80M | 4.31% |
| Mar 31, 2025 | 21.11B | 3.26B | 18.25% |
| Mar 31, 2024 | 17.85B | 4.42B | 32.92% |
| Mar 31, 2023 | 13.43B | 731.90M | 5.76% |
| Mar 31, 2022 | 12.70B | 346.97M | 2.81% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |
| Hikal | 17.35B |
| Bliss GVS Pharma | 10.05B |
| Gufic Biosciences | 9.81B |
| Venus Remedies | 8.11B |
| Fredun Pharmaceuticals | 7.44B |
Unichem Laboratories News
- 6 weeks ago - Unichem Laboratories schedules 63rd AGM for 11th August 2026 via virtual means - Business Upturn
- 2 months ago - Unichem Laboratories initiates transfer of unclaimed shares to IEPF - Business Upturn
- 3 months ago - Unichem Laboratories shares fall over 3% after weak Q4 results; Profit drops 79% YoY - Business Upturn
- 3 months ago - Unichem Laboratories Q4 Results: Net profit falls 79% YoY to Rs 10.9 crore, revenue declines 2% - Business Upturn
- 11 months ago - Unichem Laboratories shares fall 3% after €19.49 million EU penalty demand in perindopril case - Business Upturn
- 1 year ago - Unichem Pharmaceuticals recalls mislabeled Cyclobenzaprine tablets in US over safety concerns - Business Upturn
- 1 year ago - Unichem Laboratories’ Roha API facility gets VAI classification from USFDA - Business Upturn
- 1 year ago - Unichem Laboratories shares drop 4% after USFDA flags 3 procedural issues at Roha facility - Business Upturn